During the past decade, NYU Investigational Pharmacy conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "NYU Investigational Pharmacy" #1 collaborator was "National Institute for Occupational Safety and Health (NIOSH/CDC)" with 2 trials as a collaborator and "American Heart Association" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "NYU Investigational Pharmacy" are "Advanced Cancer" (1 trials), "Advanced Solid Tumors" (1 trials), "Airway Disease" (1 trials), "Avelumab in Combination With Talazoparib Will be Investigated in Patients With Locally Advanced (Primary or Recurrent) or Metastatic Solid Tumors" (1 trials) and "Barrett Esophagus" (1 trials). Many other conditions were trialed in "NYU Investigational Pharmacy" in a lesser frequency.

Most popular intervention types in "NYU Investigational Pharmacy" are "Drug" (5 trials) and "Behavioral" (1 trials). Other intervention types were less common.

The name of intervention was led by "Avelumab" (1 trials), "Avelumab (MSB0010718C)" (1 trials), "Avelumab Phase 1b" (1 trials), "Avelumab Phase 2" (1 trials) and "Axitinib (AG-013736)" (1 trials). Other intervention names were less common.

The vast majority of trials in "NYU Investigational Pharmacy" are 7 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "NYU Investigational Pharmacy". undefined are not yet recruiting, 3 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in NYU Investigational Pharmacy, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in NYU Investigational Pharmacy, 3 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".